Boston Scientific Corp [BSX] stock prices are up 1.52% to $100.73 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BSX shares have gain 4.47% over the last week, with a monthly amount drifted -4.39%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Boston Scientific Corp [NYSE: BSX] stock has seen the most recent analyst activity on January 10, 2025, when Deutsche Bank upgraded its rating to a Buy but kept the price target unchanged to $108 for it. Previously, Needham downgraded its rating to Hold on October 18, 2024. On May 30, 2024, Goldman initiated with a Buy rating and assigned a price target of $90 on the stock. Mizuho upgraded its rating to a Buy and increased its price target to $80 on February 01, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $59 as its price target on July 19, 2023. CL King started tracking with a Buy rating for this stock on June 30, 2023, and assigned it a price target of $64.
The stock price of Boston Scientific Corp [BSX] has been fluctuating between $66.80 and $107.17 over the past year. Currently, Wall Street analysts expect the stock to reach $103.2 within the next 12 months. Boston Scientific Corp [NYSE: BSX] shares were valued at $100.73 at the most recent close of the market. An investor can expect a potential return of 2.45% based on the average BSX price forecast.
Analyzing the BSX fundamentals
The Boston Scientific Corp [NYSE:BSX] reported sales of 16.75B for trailing twelve months, representing a surge of 22.44%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.09 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.51.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 99.28 points at the first support level, and at 97.84 for the second support level. However, for the 1st resistance point, the stock is sitting at 101.83, and for the 2nd resistance point, it is at 102.94.
Ratios To Look Out For
It’s worth pointing out that Boston Scientific Corp [NYSE:BSX]’s Current Ratio is 1.08. As well, the Quick Ratio is 0.64, while the Cash Ratio is 0.06. Considering the valuation of this stock, the price to sales ratio is 8.88, the price to book ratio is 6.82 and price to earnings (TTM) ratio is 80.75.
Transactions by insiders
Recent insider trading involved Woodworth Emily, SVP, Global Controller and CAO, that happened on Mar 03 ’25 when 7149.0 shares were sold. SVP, Global Controller and CAO, Woodworth Emily completed a deal on Mar 04 ’25 to sell 482.0 shares. Meanwhile, SVP, Global Controller and CAO Woodworth Emily sold 9887.0 shares on Feb 28 ’25.
